In the latest trading session, 0.65 million Hoth Therapeutics Inc (NASDAQ:HOTH) shares changed hands as the company’s beta touched 0.58. With the company’s most recent per share price at $1.09 changed hands at -$0.08 or -6.84% at last look, the market valuation stands at $14.33M. HOTH’s current price is a discount, trading about -248.62% off its 52-week high of $3.80. The share price had its 52-week low at $0.58, which suggests the last value was 46.79% up since then. When we look at Hoth Therapeutics Inc’s average trading volume, we note the 10-day average is 1.85 million shares, with the 3-month average coming to 9.33 million.
Analysts gave the Hoth Therapeutics Inc (HOTH) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended HOTH as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Hoth Therapeutics Inc’s EPS for the current quarter is expected to be -0.43.
Hoth Therapeutics Inc (NASDAQ:HOTH) trade information
Instantly HOTH was in red as seen in intraday trades today. With action -3.54%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 45.70%, with the 5-day performance at -3.54% in the red. However, in the 30-day time frame, Hoth Therapeutics Inc (NASDAQ:HOTH) is -3.54% down. Looking at the short shares, we see there were 0.17 million shares sold at short interest cover period of 0.46 days.
Hoth Therapeutics Inc (HOTH) estimates and forecasts
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 15.18%. The 2025 estimates are for Hoth Therapeutics Inc earnings to increase by 50.00%, but the outlook for the next 5-year period is at 27.42% per year.
Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.92% of Hoth Therapeutics Inc shares while 3.53% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 3.57%.
Among Mutual Funds, the top two as of Dec 31, 2024 were Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. With 38.8 shares estimated at $43010.0 under it, the former controlled 0.56% of total outstanding shares. On the other hand, Fidelity Extended Market Index Fund held about 0.51% of the shares, roughly 35.55 shares worth around $39401.0.
